查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球聲帶增強市場
市場調查報告書
商品編碼
1272776

2023-2030 年全球聲帶增強市場

Global Vocal Fold Augmentation Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球聲帶增強市場預計將實現利潤豐厚的增長，到 2022 年將達到 20.428 億美元，到 2030 年將達到 26.428 億美元。 聲帶增強市場預計在預測期內（2023-2030 年）的複合年增長率為 3.3%。 主要參與者正在採取併購、合作夥伴關係和區域擴張等戰略，以在聲帶增強市場中脫穎而出，成為強有力的競爭者。 除了高度重視研發外，新產品發布是大公司提高市場佔有率的另一種方式。

例如，2020 年 11 月 6 日，Thyssen'sche Handelsgesellschaft mbH (THG) 立即收購了 SPIGGLE &THEIS Medizintechnik GmbH（“SPIGGLE &THEIS”）的多數股權。 此外，2020 年 12 月 18 日，APrevent 和 hearLIFE 簽署了 APrevent VOIS 在韓國、新加坡、馬來西亞、泰國、印度尼西亞、越南、柬埔寨、老撾、緬甸和文萊的獨家經銷協議。

競爭因素，例如市場進入者擴大地理足跡，通過多種產品發布和新興市場擴張加強客戶群，預計將在預測期內推動市場增長。

聲帶增強術是一種增強聲帶功能的醫療程序。 它包括使用聲帶注射來治療輕度至中度聲門反流的各種永久性原因，例如聲帶萎縮，麻痺和癱瘓。 此外，它還可用於先前框架手術後的增強。

全球聲帶增強市場預計將在未來幾年出現顯著增長，原因有多種因素，例如與聲音相關的問題案例不斷增加、醫療保健意識不斷增強以及技術進步。.

此外，老年人口的增加和對微創手術的需求不斷增長也有望推動市場增長。 在過去十年中，聲帶注射作為治療各種喉部疾病的一種有價值的治療方法的出現也促進了市場的增長。

市場動態

預計喉癌患者數量的增加將推動全球聲帶增強市場的增長

全球聲帶增強市場是由日益普遍的嗓音問題（包括喉癌）推動的。 例如，根據美國癌症協會的數據，每年大約有 13,150 例新的喉癌病例，HPV 感染、吸煙和飲酒等風險因素導致病例增加。 因此，對聲帶增強以改善喉部疾病患者的發聲功能的需求不斷增長。

全球聲帶增強市場可能面臨熟練專業人員短缺的製約

隨著對優質醫護人員需求的增加，聲帶增強市場也受到醫護人員短缺的影響。 據 usnews.com 報導，預計到 2025 年，美國將面臨一些衛生專業人員的短缺，包括家庭傭工、護理助理、醫療和實驗室技術人員以及護士。 這些短缺在某些職業中最為明顯和引人注目，並可能導致在滿足聲帶成形術和治療需求方面面臨挑戰。

COVID-19 影響分析

COVID-19 疫情對全球聲帶增強市場產生了重大影響，導致醫療器械和設備的供應鍊和製造中斷。 這導致了延誤和短缺，影響了市場上產品和服務的可用性。 此外，許多醫療機構正在縮減或推遲擇期手術，包括聲帶增強手術，以優先考慮 COVID-19 患者並降低感染風險。

然而，儘管存在這些挑戰，如果由於嗓音障礙患病率的增加以及市場對創新手術技術和新產品的需求不斷增長而導致大流行情況有所改善，則市場有望復蘇。 許多製造商和服務提供商也通過提供遠程醫療服務和為醫療保健專業人員開發虛擬培訓和支持計劃來適應這一流行病。

俄烏衝突分析

當前俄羅斯和烏克蘭之間的衝突可能通過阻塞製造和分銷渠道對聲帶增強市場產生間接影響，導致產品供應短缺和成本上升，對企業的影響可能是巨大的。

然而，儘管存在這些挑戰，但由於醫療保健意識的提高以及與聲音相關的疾病患病率的上升，從長遠來看，該市場預計會擴大。 這有望為同行業的其他公司帶來商機。 儘管戰爭的短期影響和持續的大流行可能會造成破壞，但從長遠來看，市場有望復蘇並繼續繁榮。 因此，跟蹤衝突對全球醫療保健行業的影響至關重要。

內容

第一章調查方法及範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按材料類型分類的片段
  • 按治療類型
  • 最終用戶
  • 區域摘要

第四章市場動態

  • 影響因素
    • 主持人
      • 預計喉癌患者的增加將推動全球聲帶增強市場的增長
    • 約束因素
      • 缺乏熟練的專業人員可能會限制全球聲帶增強市場的增長
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法律法規分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按材料類型分類

  • 羧甲基纖維素
  • 羥基磷灰石鈣
  • 透明質酸
  • 絲綢
  • 凝膠泡沫
  • 脂肪和油
  • 其他

第 8 章按治療類型分類

  • 臨時的
  • 常任

第 9 章最終用戶

  • 醫院
  • 專科門診
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第12章公司簡介

  • Merz Holding GmbH & Co KG（Merz Pharmaceuticals, LLC）
    • 公司概況
    • 產品組合和說明
    • 財務摘要
    • 主要發展狀況
  • Sofregen Medical Inc.
  • Hoya Corporation（PENTAX Medical America, Inc.）
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Inhealth Technologies
  • APrevent Medical Inc.
  • Boston Medical Products, Inc.
  • ReGen Scientific

第13章 附錄

簡介目錄
Product Code: MD818

Market Overview

The global vocal fold augmentation market reached US$ 2,042.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,642.8 million by 2030. The vocal fold augmentation market is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030). The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the vocal fold augmentation market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.

For instance, on November 6, 2020, Thyssen'sche Handelsgesellschaft mbH (THG) acquired a majority stake in SPIGGLE & THEIS Medizintechnik GmbH ("SPIGGLE & THEIS") with immediate effect. Moreover, on December 18, 2020, APrevent and hearLIFE signed the exclusive distribution agreement for APrevent VOIS in Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Cambodia, Laos, Myanmar, and Brunei.

Fierce competition between market participants to expand their geographic footprints and strengthen their customer pool through several product launches & new product developments are major factors anticipated to drive market growth over the forecast period.

Vocal fold augmentation is a medical procedure that is performed to enhance the functioning of the vocal folds. It involves the use of vocal fold injection to treat various permanent causes of mild-to-moderate glottic insufficiency, such as vocal fold atrophy, paralysis, and paresis. Moreover, it can also be used for augmentation after previous framework surgery.

The global vocal fold augmentation market is expected to experience significant growth in the coming years, driven by various factors such as increasing cases of voice-related problems, rising awareness of healthcare, and advancements in technology.

Moreover, the growing geriatric population and rising demand for minimally invasive procedures are also expected to boost the market's growth. The emergence of vocal fold injection as a valuable treatment modality for a variety of laryngeal disorders in the past decade is also contributing to the market's growth.

Market Dynamics

The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market

The global vocal fold augmentation market is being driven by the increasing prevalence of voice problems, including laryngeal cancer. For instance, The American Cancer Society reports that there are around 13,150 new cases of laryngeal cancer each year, with risk factors such as HPV infection, tobacco use, and alcohol consumption contributing to the rise in cases. As a result, there is an increasing demand for vocal fold augmentation procedures to improve vocal function in patients with laryngeal disorders.

The global vocal fold augmentation market growth may face constraints due to a lack of skilled professionals

The vocal fold augmentation market is also affected by shortages in the healthcare workforce, as the demand for quality healthcare professionals increases. According to usnews.com, the U.S. is estimated to face shortages in several healthcare professions by 2025, including home health aides, nursing assistants, medical and lab technologists and technicians, and nurse practitioners. These shortages are most apparent and dramatic in certain professions, which could lead to challenges in meeting the demand for vocal fold augmentation procedures and treatments.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global vocal fold augmentation market, causing disruptions in the supply chain and manufacturing of medical devices and equipment. This has resulted in delays and shortages, affecting the availability of products and services in the market. Moreover, many healthcare facilities have reduced or postponed elective procedures, including vocal fold augmentation surgeries, to prioritize COVID-19 patients and reduce the risk of transmission.

However, despite these challenges, the market is expected to recover as the pandemic situation improves, driven by the growing prevalence of voice disorders and the increasing demand for innovative surgical techniques and new products in the market. Many manufacturers and service providers have also adapted to the pandemic by offering telemedicine services and developing virtual training and support programs for healthcare professionals.

Russia-Ukraine Conflict Analysis

The current conflict between Russia and Ukraine could have an indirect effect on the vocal fold augmentation market by interrupting the manufacturing and distribution channels, resulting in shortages of supplies and higher costs for products that could have a greater impact on smaller firms.

However, despite these challenges, the market is projected to expand in the long run due to a growing awareness of healthcare and the rising prevalence of voice-related disorders. This is expected to create business opportunities for companies in the industry. Although the short-term effects of the war and the ongoing pandemic may cause disruptions, the market is predicted to rebound and continue to thrive over time. As a result, it is crucial to track the impact of the conflict on the global healthcare industry as a whole.

Segment Analysis

The global vocal fold augmentation market is segmented based on material type, treatment type, end user, and region.

The carboxymethylcellulose segment is expected to hold the highest vocal fold augmentation market share

The carboxymethylcellulose segment is expected to be the dominant segment in the global vocal fold augmentation market, holding 30.7% of the market share over the forecast period. The use of carboxymethylcellulose vocal cord injection is expected to be the leading technique in the global vocal fold augmentation market. Carboxymethylcellulose (CMC) is a thickening agent derived from cellulose obtained from materials such as wood pulp or cotton lint, which is reacted with a derivative of acetic acid (found in vinegar) and is also referred to as cellulose gum.

Gels made from carboxymethylcellulose (CMC) and cross-linked hyaluronic acid are commonly used as injectable materials for temporary or resorbable vocal fold medialization. For example, PROLARYN GEL, an aqueous/glycerin/carboxymethylcellulose gel implant, is used to augment the size of displaced or deformed vocal folds so that they can meet the opposing fold in the midline, leading to improved phonation. PROLARYN GEL is particularly suitable for short-term vocal fold augmentation or for patients who want to evaluate augmentation before undergoing long-term procedures.

Geographical Analysis

The presence of major players to dominate the North America region.

The vocal fold augmentation market is expected to grow significantly in North America region over the forecast period due to the presence of key market players who hold a major global vocal fold augmentation market share of around 2/5th and also due to an increase in cases of vocal fold paresis or paralysis (VFP) caused by COVID-19 vaccination, leading to dysphonia and respiratory distress.

To address these issues, several companies, such as Sofregen Medical, Inc., are developing products like Silk Voice, a soft tissue bulking agent injection that helps with vocal fold medialization and insufficiency. Silk Voice injection helps improve phonation by increasing the size of the displaced or malformed vocal fold, allowing it to converge with the opposing fold at the midline. An urgent indication for Silk Voice injection could be vocal fold insufficiency and severe aspiration issues.

Competitive Landscape

The major global players in the market include Merz Holding GmbH & Co KG(Merz Pharmaceuticals, LLC), Sofregen Medical Inc., Hoya Corporation(PENTAX Medical America, Inc.), SPIGGLE & THEIS Medizintechnik GmbH, Inhealth Technologies, APrevent Medical Inc., and Boston Medical Products, Inc., among others.

Why Purchase the Report?

  • To visualize the global vocal fold augmentation- market segmentation based on material type, treatment type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vocal fold augmentation market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vocal fold augmentation market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Treatment Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market.
    • 4.1.2. Restraints
      • 4.1.2.1. The global vocal fold augmentation market growth may face constraints due to lack of skilled professionals.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Carboxymethylcellulose
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Calcium Hydroxylapatite
  • 7.4. Hyaluronic Acid
  • 7.5. Silk
  • 7.6. Gelfoam
  • 7.7. Fats
  • 7.8. Others

8. By Treatment Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 8.1.2. Market Attractiveness Index, By Treatment Type
  • 8.2. Temporary
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Permanent

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Merz Holding GmbH & Co KG (Merz Pharmaceuticals, LLC) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Sofregen Medical Inc.
  • 12.3. Hoya Corporation (PENTAX Medical America, Inc.)
  • 12.4. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.5. Inhealth Technologies
  • 12.6. APrevent Medical Inc.
  • 12.7. Boston Medical Products, Inc.
  • 12.8. ReGen Scientific

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us